Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian cardiac outcomes trial

Journal of Hypertension

Volumn 19, Issue 6, 2001, Pages 1139-1147

  Sever, Peter S ^a,m   Dahlöf, Björn ^b   Poulter, Neil R ^a   Wedel, Hans ^c   Beevers, Gareth ^d   Caulfield, Mark ^e   Collins, Rory ^f   Kjeldsen, Sverre E ^g   McInnes, Gordon T ^h   Mehlsen, Jesper ⁱ   Nieminen, Markku ^j   O'Brien, Eoin ^k   Ostergren, Jan ^l  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c Nordiska Halsovardshagskolan   (Sweden)

^d CITY HOSPITAL   (United Kingdom)

^e ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^f RADCLIFFE INFIRMARY   (United Kingdom)

^g ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^h WESTERN INFIRMARY   (United Kingdom)

ⁱ FREDERIKSBERG HOSPITAL   (Denmark)

^j HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^k BEAUMONT HOSPITAL   (Ireland)

^l KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^m ST MARY S HOSPITAL   (United Kingdom)

more..

Author keywords

Blood pressure; Calcium channel blocker; Cardiovascular events; Converting enzyme inhibitor; Coronary heart disease; Hypertention; Placebo; Randomized trial; Statin; Thiazide; blocker

Indexed keywords

AMLODIPINE; ATENOLOL; ATORVASTATIN; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; PERINDOPRIL; PLACEBO; STATINE DERIVATIVE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCANDINAVIA; SYSTOLIC BLOOD PRESSURE;

EID: 0034997768     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200106000-00020     Document Type: Article

References (36)

1. Antihypertensive drug therapy: Effects on stroke and coronary heart disease
2. Blood pressure, stroke and coronary heart disease. Part 1, prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
3. Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients
4. Review of preclinical data of calcium channel blockers and atherosclerosis
5. Protocol for prospective collaborative overviews of major trials of blood-pressure-lowering treatments
6. Rationale and design for the Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial (ALLHAT)
7. The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design
8. Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension: Principle results of the Hypertension Optimal Treatment (HOT) Randomised Trial
9. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
10. British hypertension society national guidelines for hypertension management 1999: A summary
11. The Sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure
12. Concomitant risk factors in hypertensives: A survey of risk factors for cardiovascular disease among hypertensives in English general practices
13. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
14. The effect of Pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
15. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
16. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
17. Prevention of coronary heart disease with pravastatin in men with hyperchotesterolaemia
18. Prospective Randomised Open Blinded End Point (PROBE) Study; a novel design for intervention trials
19. Evaluation of three devices for self-measurement of blood pressure: According to the revised British Hypertension Society Protocol: The Omron HEM-705CP, Phillips HP5332, and Nissei DS-175
20. The Losartan Intervention For Endpoint Reduction (LIFE) in hypertension study. Rationale, design and methods
21. R31 egression models in life-tables
22. Design and analysis of randomized clinical trials requiring prolonged observations of each patient. I. Introduction and design
23. Nifedipine. Dose related increase in mortality in patients with coronary heart disease
24. The risk of MI associated with antihypertensive drug therapies
25. Long term survival and use of antihypertensive medications in older persons
26. Outcome results of the fosinopril versus amlodipine cardiovascular events randomised trial (FACET) in patients with hypertension and NIDDM
27. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non insulin dependent diabetes and hypertension
28. Randomised double blinded comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators
29. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators
30. Local relaxant and constricting factors in the vessel wall
31. Guidelines sub-committee